Tag: Mayo Clinic

Vivos Inc. reports major progress in its India human trial for RadioGel®, showing high safety and localized tumor treatment precision.

Vivos Inc. advances cancer treatment with RadioGel® PRnT™ Human trials in India show early success, with Mayo Clinic expansion planned in 2025.

Vivos Inc. advances with Reg A-1 filing to support human trials and expand animal therapies, reflecting growth potential and commitment to oncology innovation.